CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses.

Source:http://linkedlifedata.com/resource/pubmed/id/15720419

Download in:

View as

General Info

PMID
15720419